Variant report
Variant | esv1794185 |
---|---|
Chromosome Location | chr5:79861520-79863544 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:79859883..79861719-chr5:79862893..79865594,2 | MCF-7 | breast: | |
2 | chr5:79859883..79861719-chr5:79862893..79865594,2 | MCF-7 | breast: | |
3 | chr5:79858408..79862630-chr5:79863192..79865325,4 | MCF-7 | breast: | |
4 | chr5:79857137..79859837-chr5:79862629..79864172,2 | MCF-7 | breast: | |
5 | chr5:79858408..79862630-chr5:79863192..79865325,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16877903 | chr5:79861520-79861521 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs151075474 | chr5:79861553-79861554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554979475 | chr5:79861580-79861581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545188402 | chr5:79861585-79861586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549939452 | chr5:79861596-79861597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144156475 | chr5:79861615-79861616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377619799 | chr5:79861620-79861621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115108984 | chr5:79861627-79861628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536159192 | chr5:79861671-79861672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555743456 | chr5:79861685-79861686 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117493204 | chr5:79861712-79861713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534703659 | chr5:79861772-79861773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141292091 | chr5:79861777-79861778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs578133810 | chr5:79861787-79861788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543672082 | chr5:79861823-79861824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201972884 | chr5:79861830-79861831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565437790 | chr5:79861831-79861832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112841917 | chr5:79861870-79861871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144812259 | chr5:79861882-79861883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553710278 | chr5:79861922-79861923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73123493 | chr5:79861972-79861973 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs188263185 | chr5:79861986-79861987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559340697 | chr5:79862042-79862043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529252393 | chr5:79862063-79862064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528138178 | chr5:79862109-79862110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576818843 | chr5:79862167-79862168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181862158 | chr5:79862198-79862199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs386689485 | chr5:79862200-79862201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7711441 | chr5:79862202-79862203 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs531016155 | chr5:79862212-79862213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550225135 | chr5:79862231-79862232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs249203 | chr5:79862233-79862234 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs117823929 | chr5:79862240-79862241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376641933 | chr5:79862264-79862265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566231570 | chr5:79862311-79862312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184836359 | chr5:79862340-79862341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138650840 | chr5:79862390-79862391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188767840 | chr5:79862434-79862435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537558386 | chr5:79862462-79862463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140325046 | chr5:79862472-79862473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373533437 | chr5:79862516-79862517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542456146 | chr5:79862561-79862562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553275778 | chr5:79862641-79862642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377462591 | chr5:79862648-79862649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573030579 | chr5:79862649-79862650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181927500 | chr5:79862713-79862714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561050914 | chr5:79862741-79862742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574742139 | chr5:79862776-79862777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564551356 | chr5:79862809-79862810 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186231119 | chr5:79862851-79862852 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:79860400-79863800 | Weak transcription | Brain Anterior Caudate | brain |
2 | chr5:79861400-79861600 | Enhancers | A549 | lung |
3 | chr5:79861400-79861800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr5:79862600-79863000 | Enhancers | A549 | lung |
5 | chr5:79862800-79863000 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr5:79862800-79863000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr5:79862800-79863200 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |